CytoDyn Inc.·4

Oct 4, 7:14 PM ET

Migliarese Antonio 4

4 · CytoDyn Inc. · Filed Oct 4, 2022

Insider Transaction Report

Form 4
Period: 2022-09-30
Migliarese Antonio
Chief Financial Officer
Transactions
  • Award

    Common Stock

    2022-09-30+10,292137,854 total
Footnotes (1)
  • [F1]Represents awards of fully vested shares under the issuer's 2012 Equity Incentive Plan approved by its Compensation Committee of the Board of Directors with a value on the respective date of grant equal to reduction in reporting person's cash salary.

Documents

1 file
  • 4
    tm2227293-2_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT